Prime Medicine, Inc. (PRME)

3.65 -0.02 (-0.54%) USD  |  NASDAQ  |  Sep 03, 13:40
More

Prime Medicine Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for PRME.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2020. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
Date Value
December 31, 2020 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Sana Biotechnology, Inc. --
Intellia Therapeutics, Inc. Upgrade
Revolution Medicines, Inc. --